Abstract: The invention provides methods of treating or preventing an ocular disease or disorder in a subject, methods of treating or preventing ocular pain or discomfort comprising, administering to the subject a composition comprising a pharmaceutically acceptable carrier and a pharmaceutically effective amount of a transient receptor potential melastatin 8 (TRPM8) antagonist. In certain preferred embodiments, the ocular disease or disorder is a dry eye disease.
Type:
Grant
Filed:
February 26, 2020
Date of Patent:
July 30, 2024
Assignee:
Ora, Inc.
Inventors:
Mark B. Abelson, Peter Corcoran, Keith Lane
Abstract: The present invention relates to an apparatus including a base, a hollow receiving element joined to the base, and at least one positioning attachment that positions an imaging device received by the hollow receiving element to capture an image of at least one eye of a user. The present invention also relates to a method of capturing at least one image of at least one eye of a user using the above described apparatus.
Type:
Grant
Filed:
December 11, 2017
Date of Patent:
February 15, 2022
Assignee:
Ora, Inc.
Inventors:
Richard Abelson, Mark B. Abelson, Endri Angjeli, Keith Lane
Abstract: Provided herein are methods of using Syk inhibitors, such as a selective Syk inhibitor, Compound 1 or a pharmaceutically acceptable salt thereof, in treating allergic and/or inflammatory diseases or conditions of the eye. Also provided is pharmaceutical compositions, in particular eyedrop ophthalmic compositions, comprising Compound 1 or a pharmaceutically acceptable salt thereof, useful in the methods.
Type:
Application
Filed:
March 8, 2019
Publication date:
February 25, 2021
Applicants:
Portola Pharmaceuticals, Inc., ORA, Inc.
Inventors:
Anjali PANDEY, Matthew CHAPIN, Harold PATTERSON, Yung Yueh HSU, Mark ABELSON
Abstract: The invention provides methods of treating or preventing an ocular disease or disorder in a subject, methods of treating or preventing ocular pain or discomfort comprising, administering to the subject a composition comprising a pharmaceutically acceptable carrier and a pharmaceutically effective amount of a transient receptor potential melastatin 8 (TRPM8) antagonist. In certain preferred embodiments, the ocular disease or disorder is a dry eye disease.
Type:
Grant
Filed:
January 27, 2017
Date of Patent:
March 31, 2020
Assignee:
Ora, Inc.
Inventors:
Mark B. Abelson, Peter Corcoran, Keith Lane
Abstract: The present invention provides methods of identifying a subject as susceptible to treatment for an ocular disease or disorder. The present invention also provides methods of screening an agent for the treatment of an ocular disease or disorder. In certain embodiments, the ocular disease or disorder is dry eye disease.
Abstract: The present invention relates to an apparatus including a base, a hollow receiving element joined to the base, and at least one positioning attachment that positions an imaging device received by the hollow receiving element to capture an image of at least one eye of a user. The present invention also relates to a method of capturing at least one image of at least one eye of a user using the above described apparatus.
Type:
Application
Filed:
December 11, 2017
Publication date:
June 14, 2018
Applicant:
Ora, Inc.
Inventors:
Richard Abelson, Mark B. Abelson, Endri Angjeli, Keith Lane
Abstract: The invention provides methods of treating or preventing an ocular disease or disorder in a subject, methods of treating or preventing ocular pain or discomfort comprising, administering to the subject a composition comprising a pharmaceutically acceptable carrier and a pharmaceutically effective amount of a transient receptor potential melastatin 8 (TRPM8) antagonist. In certain preferred embodiments, the ocular disease or disorder is a dry eye disease.
Type:
Application
Filed:
January 27, 2017
Publication date:
September 14, 2017
Applicant:
Ora, Inc.
Inventors:
Mark B. Abelson, Peter Corcoran, Keith Lane
Abstract: This is directed to systems, processes, machines, and other means that simulate blast waves from explosive events. The invention can make waveforms tailored to a user's preference to accurately model a variety of explosive events by utilizing a driver section and a transition section that have divergent geometries.
Abstract: This is directed to systems, processes, machines, and other means that simulate blast waves from explosive events. The invention can make waveforms tailored to a user's preference to accurately model a variety of explosive events by utilizing a driver section and a transition section that have divergent geometries.